Meiji Holdings Co., Ltd. (2269.T) JPX
Currency In JPY
- General
- Statistics
- Historical Data
- Profile
- Financials
Currency In JPY
Sector
Consumer Defensive
Industry
Packaged Foods
Employees
17270
First IPO Date
January 04, 2000
| Name | Title | Pay | Year Born |
| Katsunari Matsuda | CEO, President & Representative Director | 91M | 1957 |
| Bunjiro Yao | Chief Operating Officer of Food Segment, Executive Officer & Director | 84M | 1961 |
| Masashi Tanaka | General Manager of IR Dept | 0 | N/A |
| Shougo Ohishi | Executive Officer & Chief Sustainability Officer | 0 | 1964 |
| Yuhei Matsumoto | Head of Group HR Strategy & Executive Officer | 0 | N/A |
| Keiko Kawahata | Executive Officer of Wellness Science Labs | 0 | 1966 |
| Shinji Matsuoka | Managing Executive Officer, CSO & Head of Sustainable Promotion Dept. | 0 | 1960 |
| Toshiaki Nagasato | Chief Operating Officer of Pharma Segment, Executive Officer & Director | 0 | 1957 |
| Koshi Sakamoto | General Manager of Intellectual Property Strategy Dept. | 0 | N/A |
| Jun Furuta | Executive Vice President, Chief Digital Officer & Director | 0 | 1957 |
| Jun Hishinuma | Chief Financial Officer, Senior Managing Executive Officer & Director | 0 | 1965 |
| Toshiyasu Sekine | Executive Officer & Chief Human Resource Officer | 0 | 1971 |
Meiji Holdings Co., Ltd., established in Tokyo, Japan, in 1916, operates globally as a prominent manufacturer and seller across two core business segments: Food and Pharmaceutical. Its extensive Food division produces and markets a wide array of products, including various dairy items like yogurts, milk, cheeses, butter, and ice cream. This segment also encompasses a diverse selection of confectioneries, such as chocolates, gummy treats, and candies, alongside nutritional offerings like sports supplements, infant formulas, and beauty aids. Further contributions from the Food sector include frozen foods, sugar, over-the-counter medications, and livestock products, complemented by essential transportation and distribution services. The Pharmaceutical segment is dedicated to the development and provision of human health solutions, specifically targeting infectious diseases and central nervous system disorders, as well as manufacturing generic drugs, human and animal vaccines, and blood plasma products. Additionally, this division supplies a comprehensive range of veterinary medicines for livestock, fisheries, and companion animals, covering antimicrobials, pain relief, anti-inflammatory agents, and specialized treatments, alongside agricultural and livestock chemicals.